SCHEMBL3719255

SCHEMBL3719255

Nc1nc(O)cc(C2CCC2)n1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 15/20 0.56
HRH3 Q9Y5N1 1/20 0.46
CDK1 P06493 3/20 0.44
CDK2 P24941 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5750310 0.96 HRH4 (0.61) HRH4HRH3CDK1CDK2
SCHEMBL24309619 0.94 HRH4 (0.59) HRH4HRH3CDK1CDK2
SCHEMBL5750966 0.92 HRH4 (0.50) HRH4HRH3CDK1CDK2
SCHEMBL13153688 0.84 HRH4 (0.44) HRH4HRH3CDK1CDK2
SCHEMBL30488040 0.80 HRH4 (0.59) HRH4HRH3
SCHEMBL28600011 0.80 HRH4 (0.59) HRH4HRH3
SCHEMBL3718738 0.77 HRH4 (0.56) HRH4HRH3
SCHEMBL3228902 0.76 HRH4 (0.42) HRH4HRH3CDK1CDK2
Formic Acid SCHEMBL28591620 0.75 HRH4 (0.50) HRH4HRH3CDK1CDK2
SCHEMBL1615966 0.73 HRH4 (0.61) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113061116-B Aminopyrimidine compound, preparation method, composition and application thereof 上海医药工业研究院 2023-07-25 CN disclosed
CN-113061116-A Aminopyrimidine compound, preparation method, composition and application thereof 上海医药工业研究院 2021-07-02 CN disclosed
WO-2010120854-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-10-21 WO disclosed
WO-2010120854-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-10-21 WO disclosed
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 EP disclosed
EP-1321169-A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament Biofrontera Pharmaceuticals AG (DE) 2003-06-25 EP disclosed
CN-1109675-C Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2003-05-28 CN disclosed
US-5958934-A 5-HT 2B ANTAGONIST SYNTEX (U.S.A.) INC. (US) 1999-09-28 US disclosed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 US disclosed
CN-1223641-A Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 1999-07-21 CN disclosed
EP-0901474-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-17 EP disclosed
US-5863924-A Aryl pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1999-01-26 US disclosed
WO-1997044326-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-27 WO disclosed